製品: NeuN Antibody
カタログ: DF6145
タンパク質の説明: Rabbit polyclonal antibody to NeuN
アプリケーション: WB IHC IF/ICC
反応性: Human, Mouse, Rat
予測: Pig, Bovine, Horse, Sheep, Rabbit, Dog, Chicken
分子量: 45-55kD; 34kD(Calculated).
ユニプロット: A6NFN3
RRID: AB_2838112

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $280 在庫あり
 200ul $350 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先

製品説明

ソース:
Rabbit
アプリケーション:
WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse,Rat
予測:
Pig(100%), Bovine(100%), Horse(100%), Sheep(100%), Rabbit(100%), Dog(100%), Chicken(100%)
クローナリティ:
Polyclonal
特異性:
NeuN Antibody detects endogenous levels of total NeuN.
RRID:
AB_2838112
引用形式: Affinity Biosciences Cat# DF6145, RRID:AB_2838112.
コンジュゲート:
Unconjugated.
精製:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ/展開

FLJ56884; FLJ58356; Fox-1 homolog C; fox1 homolog C; Fox3; FOX3NeuN; hexaribonucleotide binding protein 3; HRNBP3; NEUN; neuronal nuclei; Rbfox3; RFOX3_HUMAN; RNA binding protein fox-1 homolog 3; RNA binding protein, fox 1 homolog (C. elegans) 3;

免疫原

免疫原:
Uniprot:
遺伝子(ID):
タンパク質の説明:
NeuN, also named as FOX3 and RBFOX3, is neuronal-specific nuclear protein with MW 38-50kd(~48kd). It is one of a family of 3 mammalian Fox homologues. FOX3(Or NeuN) functions in RNA-binding protein that regulates alternative splicing events.
タンパク質配列:
MAQPYPPAQYPPPPQNGIPAEYAPPPPHPTQDYSGQTPVPTEHGMTLYTPAQTHPEQPGSEASTQPIAGTQTVPQTDEAAQTDSQPLHPSDPTEKQQPKRLHVSNIPFRFRDPDLRQMFGQFGKILDVEIIFNERGSKGFGFVTFETSSDADRAREKLNGTIVEGRKIEVNNATARVMTNKKTGNPYTNGWKLNPVVGAVYGPEFYAVTGFPYPTTGTAVAYRGAHLRGRGRAVYNTFRAAPPPPPIPTYGAVVYQDGFYGAEIYGGYAAYRYAQPAAAAAAYSDSYGRVYAAADPYHHTIGPAATYSIGTM

種類予測

種類予測:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Pig
100
Horse
100
Bovine
100
Sheep
100
Dog
100
Chicken
100
Rabbit
100
Xenopus
0
Zebrafish
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

PTMs - A6NFN3 基板として

Site PTM Type Enzyme
S63 Phosphorylation
R116 Methylation
K167 Ubiquitination
Y187 Phosphorylation
T188 Phosphorylation

研究背景

機能:

Pre-mRNA alternative splicing regulator. Regulates alternative splicing of RBFOX2 to enhance the production of mRNA species that are targeted for nonsense-mediated decay (NMD).

細胞の位置付け:

Nucleus. Cytoplasm.
Note: Largely restricted to neuronal nuclei. However, significant cytoplasmic localization in neurons from brains from HIV-infected individuals with cognitive impairment.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location

参考文献

1). Berberine Inhibits the Disruption of the Blood-Brain Barrier and Glial Cell Activation in a Rat Model of Acute Hepatic Encephalopathy. Phytotherapy research : PTR, 2025 (PubMed: 39791947) [IF=7.2]

2). Neuroprotective effects of rapamycin on spinal cord injury in rats by increasing autophagy and Akt signaling. Neural Regeneration Research, 2019 (PubMed: 30632514) [IF=5.9]

Application: IF/ICC    Species: rat    Sample: dorsal column

Figure 2 |Immunofluorescence staining of Beclin 1, NeuN and GFAP in the dorsal column along the epicenter at 24 hours after SCI (fluorescence microscope). Double staining of Beclin 1/NeuN and Beclin 1/GFAP were observed. Fluorescence colors: NeuN: green, GFAP: green and Beclin 1: red (n = 6). Scale bars: 100 μm. RAPA: Rapamycin; SCI: spinal cord injury, GFAP: glial fibrillary acidic protein.

Application: WB    Species: rat    Sample: dorsal column

Figure 9| NeuN expression in the dorsal column at 24 hours after SCI. (A) Representative western blots showing levels of NeuN. (B) Relative band densities of NeuN. The densities of the protein bands were analyzed and normalized to β-actin. Data are expressed as the mean ± SD (n = 6; one-way analysis of variance followed by Dunnett’s t-test). *P < 0.05, vs. sham group; #P < 0.05, vs. SCI + vehicle group; ?P < 0.05, vs. SCI + RAPA group. RAPA: Rapamycin; 3-MA: 3-methyladenine; IV: Akt inhibitor IV; SCI: spinal cord injury.

3). Erythropoietin inhibits ferroptosis and ameliorates neurological function after spinal cord injury. Neural Regeneration Research, 2023 (PubMed: 36204858) [IF=5.9]

Application: IF/ICC    Species: Rat    Sample: PC12 cells

Figure 5 EPO inhibits neuronal ferroptosis via upregulating expressions of xCT and Gpx4. (A) Double-labeled immunofluorescent staining of 4-Hne (red, TRITC)/NeuN (neuronal marker, green, FITC) from injured tissue and relative fluorescence intensity analysis at 14 dpi. (B) Double-labeled immunofluorescent staining of Gpx4 (red, TRITC)/NeuN (green, FITC) from injured tissue and relative fluorescence intensity analysis at 14 dpi. (C) Double-labeled immunofluorescent staining of xCT (red, TRITC)/NeuN (green, FITC) from injured tissue and relative fluorescence intensity analysis at 14 dpi. Nuclei were stained by DAPI (blue). Scale bars: 100 μm. All data are expressed as the mean ± SD (n = 5 in each group). *P < 0.05, **P < 0.01, ***P < 0.001 (one-way analysis of variance followed by Dunnett’s multiple comparisons test). 4-Hne: 4-Hydroxynonenal; Dapi: 2-(4-amidinophenyl)-6-indolecarbamidine dihydrochloride; dpi: day(s) post injury; EPO: erythropoietin; Fer-1: ferrostatin-1; FITC: fluorescein isothiocyanate; Gpx4: glutathione peroxidase 4; IF: immunofluorescent; NeuN: neuronal nuclei antigen; RSL3: (1S,3R)-RSL3; SCI: spinal cord injury; TRITC: tetramethylrhodamine isothiocyanate; xCT: the solute carrier family 7 member 11.

4). Caveolin-1 aggravates neurological deficits by activating neuroinflammation following experimental intracerebral hemorrhage in rats. Experimental Neurology, 2023 (PubMed: 37598879) [IF=4.6]

5). Fibroblast growth factor 2 contributes to the effect of salidroside on dendritic and synaptic plasticity after cerebral ischemia/reperfusion injury. Aging (Albany NY), 2020 (PubMed: 32518214) [IF=3.9]

Application: IF/ICC    Species: rat    Sample:

Figure 10.| Sal promotes increases in dendritic spine density and synaptic-associated protein expression via upregulating the FGF2-mediated cAMP/PKA/CREB signaling pathway.(A) Examples of dendritic spines (the scale bar is 10 μm). (B, C) Density of dendritic spines. (D) Double immunofluorescence staining of PSD95-positive (green) and NeuN-positive (red) neurons from sections in each group on day 7 after MCAO/R (the scale bars are 20 and 10 μm).

6). Microglial pyroptosis induced by SENP7 via the cGAS/STING/IRF3 pathway contributes to neuronal apoptosis. Cytokine, 2025 (PubMed: 39999677) [IF=3.7]

7). Melatonin exerts neuroprotective effects in mice with spinal cord injury by activating the Nrf2/Keap1 signaling pathway via the MT2 receptor. Experimental and therapeutic medicine, 2024 (PubMed: 38125360) [IF=2.4]

Application: IF/ICC    Species: Mouse    Sample: spinal cord

Figure 4 Melatonin enhances cell viability in the spinal cord. (A and B) Immunofluorescence staining was performed to visualize and quantify the number of NeuN-positive cells in the anterior horn of the spinal cord at the lesion epicenter. The scale bar represents 200 µm. (C-E) mRNA levels of Bcl-2 and Bax, as well as the ratio of Bcl2/Bax, were evaluated in spinal cord tissue at 7 days post-injury. *P≤0.05. Mel, Melatonin; Veh, Vehicle; 4PP, 4-phenyl-2-propionamidotetralin.

8). M1 Microglia Induced Neuronal Injury on Ischemic Stroke via Mitochondrial Crosstalk between Microglia and Neurons. Oxidative Medicine and Cellular Longevity, 2022 (PubMed: 36478988)

Application: IF/ICC    Species: Rat    Sample:

Figure 7 Neurological effects of Mito/M1-BV2 and Mito/M0-BV2 on tMCAO rats. (a) After Mito/M1-BV2 was labeled red and injected into the ischemic cortex of rats, the immunofluorescent staining revealed colocalization of Mito Tracker Red-labeled microglial mitochondria with neurons labeled with anti-NeuN (green). Scale bar: 20 μm. (b) Cerebral sections (n = 5) were stained using 2,3,5-triphenyltetrachloroammonium (TTC). After ischemia for 2 h and reperfusion for 6 h, the infarct volume was calculated. In addition, Ludmila belayev (n = 5) and Zea-longa neurological scores (n = 5) were determined. The data indicate mean ± SD, ∗P < 0.05, and ∗∗∗P < 0.001. (c) The immunofluorescent staining of NeuN-positive cells (green) in ischemic region of tMCAO rats treated with Mito/M0-BV2 and Mito/M1-BV2. NeuN antibody was utilized for neuron staining in ischemic cerebral tissues of tMCAO rats (n = 3). DAPI (blue) served as the nuclear marker. NeuN-positive neuronal counts were quantified. The relative neuron number was determined by calculating the ratio of the number of NeuN-positive cells in groups to the number of NeuN-positive cells in the sham group. Scale bar: 100 μm. Data presented are mean ± SD. ∗∗∗P < 0.001. (d) TEM images of mitochondria in ischemic cerebral tissues of tMCAO rats. Scale bar: 0.5 μm.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.